$XSNX
NovAccess Global Inc Stock $xsnx

$xsnx Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000118518524000148 Filed on February 09, 2024

Income Statement

Concept	2024 Q1	2023 Q3	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue	$0.00	$0.00	$0.00
YoY Change
Gross Profit	$0.00	$0.00	$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$196.3K	$371.8K	$2.312M
YoY Change	-80.64%	50.9%	95.71%
% of Gross Profit
Research & Development	$36.28K	$38.20K	$154.4K
YoY Change	-11.6%	-18.83%	-17.06%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$232.6K	$410.0K	$2.467M
YoY Change	-77.96%	39.72%	80.37%
Operating Profit	-$232.6K	-$410.0K	-$2.467M
YoY Change	-77.96%		80.37%
Interest Expense	$106.5K	-$1.337M	$1.223M
YoY Change	-59.4%	-211.72%	-27.8%
% of Operating Profit
Other Income/Expense, Net	-$260.0K	-$20.75K	-$2.258M
YoY Change	-117.24%	-97.84%	548.33%
Pretax Income	-$492.6K	-$1.768M	-$4.725M
YoY Change	-208.56%	2960.37%	175.35%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$492.6K	-$1.768M	-$4.725M
YoY Change	-208.56%	2960.37%	175.35%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.02		-$0.23
Diluted Earnings Per Share	-$0.02	-$0.08	-$0.23
COMMON SHARES
Basic Shares Outstanding	26.37M shares	21.54M shares	20.83M shares
Diluted Shares Outstanding	28.31M shares		20.83M shares

Balance Sheet

Concept	2024 Q1	2023 Q3	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.810K	$21.42K	$21.42K
YoY Change	-55.39%	-66.66%	-66.66%
Cash & Equivalents	$9.812K	$21.42K
Short-Term Investments
Other Short-Term Assets	$75.83K	$40.83K	$40.83K
YoY Change	-6.92%	-32.68%	-32.68%
Inventory
Prepaid Expenses	$75.83K	$40.83K
Receivables
Other Receivables
Total Short-Term Assets	$85.65K	$62.25K	$62.25K
YoY Change	-17.21%	-50.16%	-50.16%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	-$5.00	-$2.00	$0.00
YoY Change	400.0%	-300.0%
TOTAL ASSETS
Total Short-Term Assets	$85.65K	$62.25K	$62.25K
Total Long-Term Assets	-$5.00	-$2.00	$0.00
Total Assets	$85.65K	$62.25K	$62.25K
YoY Change	-17.22%	-50.16%	-50.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$636.8K	$514.7K	$514.7K
YoY Change	42.51%	37.0%	37.0%
Accrued Expenses	$22.90K	$300.3K	$304.1K
YoY Change	311.04%	204.45%	194.24%
Deferred Revenue
YoY Change
Short-Term Debt	$34.00K	$21.00K	$33.50K
YoY Change	61.9%	68.0%	46.48%
Long-Term Debt Due	$2.118M	$2.166M	$2.166M
YoY Change	21.37%	71.03%	71.03%
Total Short-Term Liabilities	$6.940M	$7.861M	$7.861M
YoY Change	19.03%	64.52%	64.52%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.940M	$7.861M	$7.861M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$6.940M	$7.861M	$7.861M
YoY Change	19.03%	64.52%	64.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$66.09M	-$66.90M
YoY Change	2.7%	7.6%
Common Stock	$49.12M	$49.02M
YoY Change	12.61%	13.4%
Preferred Stock	$4.747M	$4.747M
YoY Change	12.73%	0.0%
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$6.854M	-$7.798M	-$7.798M
YoY Change
Total Liabilities & Shareholders Equity	$85.65K	$62.25K	$62.25K
YoY Change	-17.22%	-50.16%	-50.16%

Cashflow Statement

Concept	2024 Q1	2023 Q3	2023
OPERATING ACTIVITIES
Net Income	-$492.6K	-$1.768M	-$4.725M
YoY Change	-208.56%	2960.37%	175.35%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$61.19K	-$154.9K	-$624.6K
YoY Change	-68.97%	-21.61%	-30.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$50.00K
YoY Change			-71.46%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	69.50K	114.8K	$581.8K
YoY Change	-61.44%	-33.2%	-26.08%
NET CHANGE
Cash From Operating Activities	-61.19K	-154.9K	-$624.6K
Cash From Investing Activities
Cash From Financing Activities	69.50K	114.8K	$581.8K
Net Change In Cash	8.310K	-40.05K	-$42.84K
YoY Change	-149.03%	55.9%	-63.2%
FREE CASH FLOW
Cash From Operating Activities	-$61.19K	-$154.9K	-$624.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-29621
CY2023	dei	Entity Registrant Name EntityRegistrantName	NovAccess Global Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	8584 E. Washington Street #127
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Chagrin Falls
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	44023
CY2023	dei	City Area Code CityAreaCode	213
CY2023	dei	Local Phone Number LocalPhoneNumber	642-9268
CY2023	dei	Security12b Title Security12bTitle	None
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Public Float EntityPublicFloat	1319074	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26373572	shares
CY2023	dei	Auditor Firm AuditorFirmId	2738
CY2023	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2023	dei	Auditor Location AuditorLocation	The Woodlands, TX
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21415	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64251	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	40833	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	60650	usd
CY2023Q3	us-gaap	Assets Assets	62248	usd
CY2022Q3	us-gaap	Assets Assets	124901	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	514686	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	375682	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1982567	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1486561	usd
CY2023Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	2982382	usd
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	1440012	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	181217	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	186217	usd
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	21000	usd
CY2022Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	12500	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	0	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	340503	usd
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2166380	usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1266627	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	2132	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	12500	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	10368	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7860732	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4777967	usd
CY2023Q3	us-gaap	Liabilities Liabilities	7860732	usd
CY2022Q3	us-gaap	Liabilities Liabilities	4777967	usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	6	usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	6	usd
CY2023Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21744209	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21744209	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18669507	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18669507	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	43683197	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	43225982	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5335398	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5340398	usd
CY2023Q3	xsnx	Additional Paid In Capital Common Stock Warrants AdditionalPaidInCapitalCommonStockWarrants	5338273	usd
CY2022Q3	xsnx	Additional Paid In Capital Common Stock Warrants AdditionalPaidInCapitalCommonStockWarrants	4210960	usd
CY2023Q3	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	4747108	usd
CY2022Q3	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	4747108	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-66902466	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62177520	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-7798484	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-4653066	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	62248	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	124901	usd
CY2023	us-gaap	Revenues Revenues	0	usd
CY2022	us-gaap	Revenues Revenues	0	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2023	us-gaap	Gross Profit GrossProfit	0	usd
CY2022	us-gaap	Gross Profit GrossProfit	0	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	154362	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	186115	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2312399	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1181534	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	2466761	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1367649	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2466761	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1367649	usd
CY2022	us-gaap	Other Income OtherIncome	0	usd
CY2023	us-gaap	Other Income OtherIncome	56082	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	237465	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	277716	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-54813	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1246842	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2084242	usd
CY2023	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	81500	usd
CY2022	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	961000	usd
CY2023	us-gaap	Interest Expense InterestExpense	1223390	usd
CY2022	us-gaap	Interest Expense InterestExpense	1694455	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2258185	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-348310	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4724946	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1715959	usd
CY2023	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	44241	usd
CY2022	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4769187	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1715959	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.1
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.1
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20828079	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16525643	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20828079	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16525643	shares
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-3928094	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	184474	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	155625	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	170200	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	370875	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	104813	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1715959	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-4653066	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	307715	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	82500	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	12000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	563315	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	563998	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4724946	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-7798484	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4724946	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1715959	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	918578	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1534932	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1246842	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2084242	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	237465	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	277716	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-54813	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	307715	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	155625	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	563315	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023	xsnx	Warrants Issued For Loan Extension WarrantsIssuedForLoanExtension	563998	usd
CY2022	xsnx	Warrants Issued For Loan Extension WarrantsIssuedForLoanExtension	0	usd
CY2023	xsnx	Fair Value Of Commitment Shares Issued For Loan Extension FairValueOfCommitmentSharesIssuedForLoanExtension	82500	usd
CY2022	xsnx	Fair Value Of Commitment Shares Issued For Loan Extension FairValueOfCommitmentSharesIssuedForLoanExtension	370875	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-19817	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	33184	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	139004	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	186565	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	496006	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	904802	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-624636	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-903489	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	175200	usd
CY2023	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	5000	usd
CY2022	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	150000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	693550	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1312500	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	-165250	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	-644250	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	8500	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	100000	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	6378	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	581800	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	787072	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-42836	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-116417	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64251	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180668	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21415	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64251	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	97928	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	107574	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	usd
CY2022	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	184474	usd
CY2023Q3	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	82500	usd
CY2022Q3	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	370875	usd
CY2023	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	12000	usd
CY2022	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	104813	usd
CY2020Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-1,000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements. Significant estimates made in preparing these consolidated financial statements include the estimate of the deferred tax valuation allowance, the fair value of stock options, and derivative liabilities. Actual results could differ from those estimates.</p>
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4724946	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1715959	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20828079	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16525643	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20828079	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16525643	shares
CY2022Q3	us-gaap	Derivative Assets DerivativeAssets	0	usd
CY2022Q3	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	1207403	usd
CY2022Q3	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	232609	usd
CY2022Q3	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	1440012	usd
CY2023Q3	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	2253391	usd
CY2023Q3	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	728991	usd
CY2023Q3	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	2982382	usd
CY2021Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	2926622	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	875348	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings	-2084242	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-277716	usd
CY2022Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	1440012	usd
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	813711	usd
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings	966124	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-237465	usd
CY2023Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	2982382	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	25000	shares
CY2023	us-gaap	Stock Issued During Period Shares Period Increase Decrease StockIssuedDuringPeriodSharesPeriodIncreaseDecrease	3074702	shares
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	307715	usd
CY2023	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1908025	shares
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	525000	shares
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	50000	usd
CY2023	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	500000	shares
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	82500	usd
CY2022	us-gaap	Stock Issued During Period Shares Period Increase Decrease StockIssuedDuringPeriodSharesPeriodIncreaseDecrease	4265477	shares
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1502670	shares
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	155625	usd
CY2022	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	546807	shares
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	791000	shares
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	170200	usd
CY2022	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	1175000	shares
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	370875	usd
CY2022	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	250000	shares
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	104813	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2166380	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2023Q3	us-gaap	Convertible Debt ConvertibleDebt	2166380	usd
CY2013Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	12000	usd
CY2013Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	4.5
CY2013Q4	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	1200	usd
CY2023	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	44241	usd
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.5
CY2022Q3	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	The loan terms required repayment of all amounts outstanding under the loan on the earlier of: (a) October 31, 2022, or (b) the receipt by the Company of debt or equity financing of $3 million
CY2022Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-04-30
CY2023Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	8500	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1500000	shares
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	44241	usd
CY2022Q2	xsnx	Class Of Warrant Or Rights Granted ClassOfWarrantOrRightsGranted	1000000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2023Q1	xsnx	Class Of Warrant Or Rights Granted ClassOfWarrantOrRightsGranted	1000000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.2
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	148500	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.2
CY2023Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023Q2	xsnx	Class Of Warrant Or Rights Granted ClassOfWarrantOrRightsGranted	1000000	shares
CY2023Q2	xsnx	Class Of Warrant Or Rights Granted ClassOfWarrantOrRightsGranted	500000	shares
CY2023Q2	xsnx	Class Of Warrant Or Rights Granted ClassOfWarrantOrRightsGranted	500000	shares
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	238412	usd
CY2023Q2	xsnx	Class Of Warrant Or Rights Granted ClassOfWarrantOrRightsGranted	750000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0001
CY2023Q3	xsnx	Class Of Warrant Or Rights Granted ClassOfWarrantOrRightsGranted	2000000	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.2
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	177086	usd
CY2023Q3	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	728991	usd
CY2022Q3	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	232609	usd
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2000000	shares
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.01
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0032	pure
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.46	pure
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.175
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3542857	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0368	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.4679	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2000000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.01
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3542857	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.175
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5542857	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.115
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	24950000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-962410	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-163760	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	708725	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-127326	usd
CY2023	xsnx	Income Tax Reconciliation Deferred Compensation IncomeTaxReconciliationDeferredCompensation	47620	usd
CY2022	xsnx	Income Tax Reconciliation Deferred Compensation IncomeTaxReconciliationDeferredCompensation	30160	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	19950	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	690	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	186115	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	260236	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5239461	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5055031	usd
CY2023Q3	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	46147	usd
CY2022Q3	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	46147	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	120070	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	72446	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	40576	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	20626	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5446254	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5194250	usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	300255	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	98621	usd
CY2023Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3875	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4740	usd
CY2023Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	571763	usd
CY2022Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	344983	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	40402	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	40402	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	23772	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	36815	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1982567	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1486561	usd
CY2020Q3	xsnx	Agreement Monthly Amount AgreementMonthlyAmount	30000	usd
CY2020Q3	xsnx	Agreement Term AgreementTerm	P3Y
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	40000	usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	us-gaap	Interest Paid InterestPaid	583	usd
CY2021Q4	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	25000	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	125000	shares
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-37500	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	226	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-54813	usd
CY2022Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1502670	shares
CY2022Q1	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.35
CY2022Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	525934	usd
CY2022Q1	xsnx	Common Stock Outstanding Percentage CommonStockOutstandingPercentage	0.10	pure
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	250000	usd
CY2023Q3	us-gaap	Payable Preferred Stock Redeemed PayablePreferredStockRedeemed	95000	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	12500	usd
CY2023Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	8500	usd
CY2022Q1	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	24400	shares
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1502670	shares
CY2023	xsnx	Common Stock Outstanding Percentage CommonStockOutstandingPercentage	0.10	pure
CY2023Q3	us-gaap	Payable Preferred Stock Redeemed PayablePreferredStockRedeemed	95000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	7500000	shares
CY2021Q4	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	25000	usd
CY2021Q4	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	The notes were payable on demand with a five business-day written notice
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	125000	shares
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-17313	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001039466
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true

Files In Submission

Name	View Source	Status
0001185185-24-000148-index-headers.html	Edgar Link	pending
0001185185-24-000148-index.html	Edgar Link	pending
0001185185-24-000148.txt	Edgar Link	pending
0001185185-24-000148-xbrl.zip	Edgar Link	pending
ex_622466.htm	Edgar Link	pending
ex_622467.htm	Edgar Link	pending
ex_622468.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mk_logo.jpg	Edgar Link	pending
novaccess20230930_10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
novaccess20230930_10k_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xsnx-20230930.xsd	Edgar Link	pending
xsnx-20230930_def.xml	Edgar Link	unprocessable
xsnx-20230930_lab.xml	Edgar Link	unprocessable
xsnx-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
xsnx-20230930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XSNX
NovAccess Global Inc Stock $xsnx

2024 Q1 Form 10-K Financial Statement

#000118518524000148 Filed on February 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XSNX NovAccess Global Inc Stock $xsnx

2024 Q1 Form 10-K Financial Statement

#000118518524000148 Filed on February 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XSNX
NovAccess Global Inc Stock $xsnx